Nephropathy Clinical Trial
Official title:
Amniotic Fluid Biomarker Research for Prediction of Postnatal Renal Function in Fetus With a Bilateral Abnormal Renal Development: National, Multicenter, Prospective and Non-interventional Study.
The discovery of antenatal bilateral renal anomaly poses an essential question: can we
predict postnatal renal function? Ultrasound is insufficiently precise to predict postnatal
renal function evolution.
The objective of this study is to estimate the specificity and sensitivity of amniotic fluid
biomarkers to predict postnatal renal function in fetuses with bilateral developmental
nephropathies.
Both fetuses with bilateral renal anomalies and control (healthy) fetuses will be included.
For this study amniotic fluid will only be collected according to routine clinical practice
and only excess amniotic fluid sample will be used for the study.
The potentially identified biomarkers will not change routine management of the pregnancies
in the study.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
Recruiting |
NCT01448889 -
Normobaric Hyperoxygenation for Prevention of Contrast Induced Nephropathy
|
N/A | |
Active, not recruiting |
NCT05026021 -
Prediction of BKvirus Nephropathy Risk by the NEPHROVIR Method in Kidney Transplant Patients With BKvirus Viremia
|
||
Completed |
NCT02470247 -
Interest of Remote Ischemic Preconditioning for Prevention of Contrast Medium-induced Nephropathy in High Risk Patients
|
N/A | |
Recruiting |
NCT05511779 -
Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation
|
Phase 2 | |
Active, not recruiting |
NCT03620773 -
Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03584217 -
Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study
|
Phase 1/Phase 2 | |
Completed |
NCT03618420 -
Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function
|
Phase 1/Phase 2 | |
Completed |
NCT02575092 -
The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment
|
Phase 2/Phase 3 | |
Recruiting |
NCT05839314 -
Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy
|
Phase 4 | |
Completed |
NCT01638663 -
Effect of the Aquaretic Tolvaptan on Nitric Oxide System (TORA)
|
Phase 2 | |
Completed |
NCT01213498 -
The Effects of Atorvastatin on the Nitric Oxide-system in Patients With Non-diabetic Nephropathy
|
Phase 2 | |
Completed |
NCT01208701 -
The Effects of Atorvastatin on the Nitrogen Oxide-system in Patients With Type 2 Diabetes and Nephropathy
|
Phase 2 | |
Completed |
NCT01214746 -
The Effects of Atorvastatin on the Nitric Oxide-system in Healthy Young Man
|
Phase 2 | |
Active, not recruiting |
NCT00655330 -
Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy
|
N/A | |
Completed |
NCT00308347 -
A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED)
|
Phase 3 | |
Terminated |
NCT00579995 -
A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate
|
N/A | |
Completed |
NCT05986474 -
Development of Synthetic Medical Data Generation Technology to Predict Postoperative Complications
|
||
Recruiting |
NCT03886714 -
Screening for Fabry Disease in Renal Transplantation
|
||
Recruiting |
NCT06325059 -
The Role of Renal Progenitors and Polyploid Tubular Cell Response in Glomerular and Tubular Diseases
|
N/A |